Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Thoracic Malignancies
What would be your post-operative therapy approach for a high grade neuroendocrine carcinoma of the thymus?
What if there was mediastinal nodal involvement?
Answer from: Radiation Oncologist at Academic Institution
Postoperative RT.
Sign In
or
Register
to read more
13071
Related Questions
Do more fractionated regimens reduce severe toxicity over SBRT in patients with ILD and early-stage NSCLC?
Do you use an LAD constraint in the setting of BID thoracic radiation for SCLC?
How does neoadjuvant chemo-immunotherapy impact your decision on hypofractionation/dose fractionation for locally advanced NSCLC, now getting RT alone?
Is there a role for the addition of radiation to preoperative chemoimmunotherapy in NSCLC with limited N2 disease planned for surgery?
What target expansions do you use when treating with 60 Gy in 15 fractions for the lung?
Can palliative radiation be used to treat recurrent malignant pleural effusion in NSCLC?
Is there a concern for using FFF beams in single isocenter multi target lung SBRT?
How does metaplastic thymoma histology impact your decision regarding adjuvant radiation?
In a patient who underwent cryoablation for early NSCLC, is there a role for giving preemptive further local therapy?
How do you talk with your patients regarding radiographic expectations on surveillance CT after lung SBRT?